Clinical Benefit of American College of Chest Physicians Versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation.
作者信息
Andrade Ambar A, Gage Brian F
机构信息
Washington University in St. Louis, 660 S. Euclid Ave, Campus Box 8005, St. Louis, MO, 63110, USA.
Texas Heart Institute, 6720 Bertner, MC 1-133, Houston, TX, 77030, USA.
出版信息
J Gen Intern Med. 2015 Oct;30(10):1405. doi: 10.1007/s11606-015-3378-3.
Abstract
摘要
相似文献
1
Clinical Benefit of American College of Chest Physicians Versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation.
J Gen Intern Med. 2015 Oct;30(10):1405. doi: 10.1007/s11606-015-3378-3.
2
Capsule Commentary on Andrade et al., Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation.对安德拉德等人的述评：美国胸科医师学会与欧洲心脏病学会心房颤动卒中预防指南的临床益处
J Gen Intern Med. 2015 Jun;30(6):833. doi: 10.1007/s11606-015-3262-1.
3
Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation.美国胸科医师学会与欧洲心脏病学会房颤卒中预防指南的临床益处
J Gen Intern Med. 2015 Jun;30(6):777-82. doi: 10.1007/s11606-015-3201-1. Epub 2015 Feb 10.
4
Comparison of Atrial Fibrillation Guidelines.心房颤动指南比较
J Gen Intern Med. 2015 Oct;30(10):1404. doi: 10.1007/s11606-015-3379-2.
5
2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview.2015年美国心脏病学会/心律学会/心血管造影和介入学会左心耳封堵装置的社会概况。
J Am Coll Cardiol. 2015 Sep 29;66(13):1497-513. doi: 10.1016/j.jacc.2015.06.028. Epub 2015 Jun 29.
6
New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.欧洲心脏病学会心房颤动管理新指南中预防卒中的新概念与新方法。
Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1643-7. doi: 10.1586/erc.10.150.
7
Practice implications of the Atrial Fibrillation Guidelines.心房颤动指南的实践意义。
Am J Cardiol. 2013 Jun 1;111(11):1660-70. doi: 10.1016/j.amjcard.2013.01.338. Epub 2013 Mar 16.
8
[Choosing wisely recommendations in cardiology].
Internist (Berl). 2017 Jun;58(6):556-567. doi: 10.1007/s00108-017-0239-7.
9
The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?2010年欧洲心脏病学会心房颤动管理指南：是演进还是变革？
Chest. 2011 Apr;139(4):738-741. doi: 10.1378/chest.10-2763.
10
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.指南比较：心房颤动患者优化卒中预防的抗凝治疗
J Am Coll Cardiol. 2004 Mar 17;43(6):929-35. doi: 10.1016/j.jacc.2003.11.028.
本文引用的文献
1
Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.在 CHA2DS2-VASc 评分为 1 的房颤患者中，抗凝治疗获益的可能性不大。
J Am Coll Cardiol. 2015 Jan 27;65(3):225-32. doi: 10.1016/j.jacc.2014.10.052.
2
Risk of bleeding with dabigatran in atrial fibrillation.达比加群酯在心房颤动中的出血风险。
JAMA Intern Med. 2015 Jan;175(1):18-24. doi: 10.1001/jamainternmed.2014.5398.
3
Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.达比加群酯预防房颤卒中的成本效果分析。
Circulation. 2011 Jun 7;123(22):2562-70. doi: 10.1161/CIRCULATIONAHA.110.985655. Epub 2011 May 23.
4
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.荟萃分析：抗栓治疗预防非瓣膜性心房颤动患者的卒中
Ann Intern Med. 2007 Jun 19;146(12):857-67. doi: 10.7326/0003-4819-146-12-200706190-00007.
5
Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.老年房颤患者华法林治疗第一年的大出血情况及耐受性
Circulation. 2007 May 29;115(21):2689-96. doi: 10.1161/CIRCULATIONAHA.106.653048. Epub 2007 May 21.
6
Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.心房颤动中基于偏好的抗栓治疗：对临床决策的影响。
Med Decis Making. 2005 Sep-Oct;25(5):548-59. doi: 10.1177/0272989X05280558.
Zotero 插件